BREAKING NEWS- AIS - Bladder control drug news out!
Not very exciting, until you realize this is a new version of a drug that has sales in the BILLIONS of dollars.
AIS - Phase II positive studies announced. Do some dd on this one.
This company spiked on the news and now at $1.43 appears to be good entry.
This is AMEX stock, and could be an investment, not just a trade. It's new bladder gel, is already a billion dollar seller by oral form, so the gel absorption they are testing, is a breakthrough, more even absorption for bladder control.
Do some DD on AIS folks. Here is the NEWS...
Antares says positive results for bladder treatment
Wed Feb 22, 2006 7:43 AM ET
CHICAGO, Feb 22 (Reuters) - Antares Pharma Inc. (AIS.A: Quote, Profile, Research) on Wednesday reported positive results from a clinical trial of its treatment for overactive bladder and said it expects to begin a pivotal Phase III trial during the second half of 2006.
The drug, Anturol, is a gel-based transdermal treatment for overactive bladder, a common urological condition.
FACT BOX
AIS.A (Antares Pharma Inc)
Last: $1.43
Change: +0.05
Antares says positive results for bladder treatment
The gel is a clear and odorless formulation of oxybutynin designed to be absorbed through the skin following once-a-day application on the abdomen, shoulders, or thighs.
